Post Profile






SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

PRESS RELEASE: SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), today announced it has closed a $35 million Series D round of financing. Deerfield Management Company,...
read more

share

Related Posts


P97 Networks Closes $8 Million Series A Funding Round Led by Emerald Technology Ventures and ATAPCO

Technology : Venture Beat

Press Release: P97 Networks, developers of PetroZone, a cloud based mobile commerce and behavioral marketing platform for the convenience and fuel retailing industry, announced today the closing of an $8 million Series A funding. Th...

Medtronic Announces U.S. Trial Of Unique Therapy For Closure Of The Left Atrial Appendage

Health : Medical News Today

Medtronic, Inc. (NYSE: MDT) announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device by Dr. Patrick McCarthy, co-director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospi...

Jersey Shore University Medical Center is First Hospital in New Jersey to Implant Watchman LAAC - A Breakthrough Treatment for Atrial Fibrillation

Health : Newswise Medical News

Jersey Shore University Medical Center - part of Meridian CardioVascular Network - became the first hospital in New Jersey to perform the newly approved Watchman Left Atrial Appendage Closure (LAAC) Implant procedure, providing pati...

SentreHEART’s LARIAT Surgical Left Atrial Appendage Suture Delivery Device Coming to Europe

Industries / Medical : medGadget

SentreHEART out of Redwood City, California obtained the CE Mark in Europe to introduce the LARIAT Surgical left atrial appendage (LAA) suture delivery device. The device allows for relatively easy placement of a 50 mm pre-tied sutu...

Boston Sci’s WATCHMAN FLX Left Atrial Appendage Closure Approved in Europe

Industries / Medical : medGadget

Boston Scientific won CE Mark approval and is reporting first implantations of its new WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. The implant is completely repositionable and removable, and is based on the original po...

Comments


Copyright © 2016 Regator, LLC